Post-translational modifications (PTMs) such as palmitoylation are critical for the lytic cycle of the protozoan parasite Toxoplasma gondii. While palmitoylation is involved in invasion, motility, and cell morphology, the proteins that utilize this PTM remain largely unknown. Using a chemical proteomic approach, we report a comprehensive analysis of palmitoylated proteins in T. gondii, identifying a total of 282 proteins, including cytosolic, membraneassociated, and transmembrane proteins. From this large set of palmitoylated targets, we validate palmitoylation of proteins involved in motility (myosin light chain 1, myosin A), cell morphology (PhIL1), and host cell invasion (apical membrane antigen 1, AMA1). Further studies reveal that blocking AMA1 palmitoylation enhances the release of AMA1 and other invasion-related proteins from apical secretory organelles, suggesting a previously unrecognized role for AMA1. These findings suggest that palmitoylation is ubiquitous throughout the T. gondii proteome and reveal insights into the biology of this important human pathogen.
In Brief
Palmitoylation is a lipid-derived posttranslational modification (PTM). Foe et al. report a comprehensive analysis of palmitoylated proteins in Toxoplasma gondii. They demonstrate that palmitoylation is associated with diverse aspects of T. gondii biology, including motility and morphology, and reveal a function for this PTM in regulating the invasion-associated protein, AMA1.
INTRODUCTION
The phylum Apicomplexa is composed of medically relevant parasites, including Plasmodium falciparum and Toxoplasma gondii, the causative agents of malaria and toxoplasmosis, respectively. T. gondii is an obligate intracellular parasite that infects approximately 30% of the world's population (RobertGangneux and Dardé , 2012) . The majority of infections are latent, asymptomatic, and maintained indefinitely inside the host as bradyzoite cysts. If an infected person becomes immunocompromised, cyst activation can cause acute toxoplasmosis, the symptoms of which include blindness and neurological problems (Montoya and Liesenfeld, 2004; Robert-Gangneux and Dardé , 2012) . The T. gondii asexual lytic cycle comprises several distinct processes, including host cell invasion, intracellular replication, and egress (Black and Boothroyd, 2000) . Completion of this cycle by tachyzoite-stage parasites is essential for parasite survival within a host, and a better understanding of these processes is prerequisite for the development of therapies to combat infection.
Recent work has implicated the post-translational modification (PTM) S-palmitoylation as being important for the tachyzoite lytic cycle (Alonso et al., 2012) . S-palmitoylation is the covalent attachment of palmitate ( Figure 1A ), a saturated 16-carbon fatty acid, via a thioester linkage to a cysteine residue (Linder and Deschenes, 2007; Tom and Martin, 2013) . Palmitoylation typically regulates protein membrane localization, but can also alter protein stability, protein/protein interactions, and protein trafficking (Linder and Deschenes, 2007; Salaun et al., 2010) . Unlike other lipid modifications, palmitoylation is reversible and dynamic (Martin et al., 2012) . The addition of palmitate is catalyzed by palmitoyl acyl transferases (PATs) (Linder and Deschenes, 2007) . The T. gondii genome encodes 18 potential PATs, 16 of which are expressed in tachyzoites (Fré nal et al., 2013) . There are two primary families of palmitoyl thioesterases: palmitoyl protein thioesterases, which remove palmitate from proteins found in lysosomes, and acyl-protein thioesterases (APTs), which target palmitoylated cytosolic proteins (Linder and Deschenes, 2007) . The T. gondii genome is predicted to encode four APTs (Kemp et al., 2013) , only one of which has confirmed thioesterase activity (Child et al., 2013) .
A growing body of work has implicated palmitoylation in multiple aspects of T. gondii biology. Treating tachyzoites with the broadly reactive PAT inhibitor, 2-bromopalmitate (2-BP), inhibits motility and host cell invasion and disrupts parasite morphology (Alonso et al., 2012) . Similarly, 2-BP treatment of blood-stage P. falciparum inhibits invasion and alters parasite morphology (Jones et al., 2012) . Inhibition of a T. gondii APT (TgPPT1) results in increased motility and invasion (Child et al., 2013) . Despite the importance of palmitoylation in the T. gondii asexual life cycle, only five proteins have been definitively shown to be palmitoylated, with mutational studies suggesting that eight others likely have this PTM (Table 1 ). The full extent of protein palmitoylation in T. gondii remains largely unknown and likely regulates many aspects of parasite biology.
To understand the extent and function of palmitoylation in T. gondii tachyzoite biology, we undertook a chemical proteomic study to profile the full complement of palmitoylated proteins in T. gondii tachyzoites. These efforts identified proteins involved in a variety of biological processes, including host cell invasion, motility, morphology, signaling, stress response, and metabolism. We biochemically confirm the palmitoylation of several candidates from our proteomic analysis, including myosin light chain 1 (MLC1) and myosin A (MyoA), components of the glideosome, the parasite's motility complex (Herm-Gö tz et al., 2002; Meissner et al., 2002) . We confirm that the morphology-associated photosensitized INA-labeled protein (PhIL1) (Barkhuff et al., 2011; Gilk et al., 2006) is palmitoylated. Unexpectedly, we found that apical membrane antigen 1 (AMA1), a protein that functions during invasion (Hehl et al., 2000; Lamarque et al., 2014; Mital et al., 2005) , is palmitoylated. Mutation of the identified palmitoylation site has no effect on invasion or protein localization but markedly enhances microneme secretion and affects the ability of parasites to complete the intracellular stages of the lytic cycle. Combined, these findings reveal a valuable dataset that will help to drive the discovery of specific functional roles for palmitoylation in T. gondii tachyzoite biology.
RESULTS

Identification of Palmitoylated Proteins by Mass Spectrometry
There have been a number of recent technological advances in the use of chemical tools to study lipidated proteins (Hang et al., 2007; Hannoush and Arenas-Ramirez, 2009; Heal et al., 2008; Kostiuk et al., 2008; Martin and Cravatt, 2009 ). This includes the development of methods to apply the palmitic acid analog 17-octadecynoic acid (17-ODYA) as a bioorthogonal tag to identify palmitoylated proteins ( Figure 1A ) (Jones et al., 2012; Martin and Cravatt, 2009 ). This palmitate mimetic contains a terminal alkyne for ''Click'' reaction (copper-catalyzed cycloaddition) with azide-containing molecules such as biotin (for affinity enrichment), or rhodamine (for in-gel visualization by SDS-PAGE) (Martin and Cravatt, 2009) . We have previously used 17-ODYA to metabolically label T. gondii tachyzoites for direct detection of specific palmitoylated proteins (Child et al., 2013) . We therefore applied this method more broadly to globally profile palmitoylation in T. gondii.
To ensure complete analysis of all palmitoylated proteins, we first determined the kinetics of labeling by 17-ODYA. We observed metabolic incorporation of 17-ODYA on proteins within 1 hr of incubation, with labeling saturated by 16 hr ( Figure S1A ). We then treated parasites for 16 hr with a range of concentrations of 17-ODYA to determine the optimal concentration to use for our proteomic studies ( Figure S1B ). We chose a concentration of 25 mM as it gave robust and consistent labeling, was not toxic ( Figure S1C) , and was the concentration used for prior human and P. falciparum palmitoylation studies (Jones et al., 2012; Martin and Cravatt, 2009 ). For our proteomic workflow, we metabolically labeled wild-type tachyzoites (RH strain) with either 17-ODYA or palmitic acid for 16 hr, sonicated the parasites, and fractionated the resulting material into soluble and Figure S1 and Table S1. insoluble fractions. Previous studies employing this approach have not observed significant 17-ODYA-dependent labeling of soluble proteins (Martin and Cravatt, 2009 ), and we focused on insoluble proteins for the remainder of the study. Accordingly, this study does not include analysis of potentially soluble palmitoylated proteins. After chloroform/methanol precipitation, we performed click conjugation of azido-biotin in the insoluble membrane fraction and collected labeled proteins by streptavidin enrichment. Following trypsin digestion, we analyzed the peptides by 1D reverse-phase nanoUPLC coupled to a quadrupole ion mobility time of flight mass spectrometer. We acquired data using UDMS E methods (Distler et al., 2014) for label-free data-independent acquisition (DIA). In this approach, data are collected across the entire mass range, cycling between low collision energy (precursors) and high collision energy (products), recording data for all precursor and product ions across the entire elution gradient. After multi-dimensional alignment by drift and elution times, precursor ions are matched to product ions for database annotation using a 1% reverse-decoy false discovery rate (FDR). Leveraging this DIA approach, we extracted ion intensities for each annotated peptide across each 1D experiment (four biological replicates, each the average of three technical replicates) and normalized each dataset to pyruvate carboxylase, an endogenous biotinylated protein. This approach yielded statistically robust, reproducible, label-free quantitation with no gaps in data across experiments. In control experiments using a standard HeLa digest (n = 4), the technical error was approximately 17% (SD), ensuring statistically significant quantitation of as little as 35% changes (2 SD) ( Figure S1D ). Based on slightly more stringent thresholds, we identified and quantified 501 T. gondii proteins statistically enriched (p < 0.05, >1.5-fold, 5% FDR) in 17-ODYA relative to the palmitic acid control ( Figure 1B , Table S1 ). In addition to reversible S-palmitoylation, palmitate can be irreversibly attached to the hydroxyl group of serine residues (O-palmitoylation) (Zou et al., 2011) and to the amine group on N-terminal cysteines (N-palmitoylation) (Linder and Deschenes, 2007) . It can also be irreversibly incorporated into glycosylphosphatidylinositol (GPI) anchors such as on T. gondii, Subtilisin 1 (SUB1) (Binder et al., 2008) . Consistent with this, SUB1 was highly enriched in 17-ODYA samples (Table S1 ). Therefore, to focus S-palmitoylated proteins, we performed a second proteomic experiment where we treated samples with hydroxylamine to hydrolyze any thioester linkages ( Figure 1C ). Following label-free DIA analysis, we confirmed statistically significant (p < 0.05) hydroxylamine hydrolysis for 282 proteins ( Figure 1C , Table S1 ), 210 of which were enriched >1.5-fold in the untreated sample (highly hydroxylamine sensitive) and 72 of which were enriched between 1-and 1.5-fold (sensitive). These 282 proteins represent our final list of T. gondii palmitoylated proteins. (Figure 2A , Table S1 ). Importantly, this included 9 of the 13 established palmitoylated proteins in our data ( Table 1 ), suggesting that the method was sufficiently robust to annotate the vast majority of palmitoylated proteins. We predict this is an underrepresentation of the number of T. gondii palmitoylated proteins, as our analysis did not use extensive fractionation and focused on a single life cycle stage. Nonetheless, the high statistical confidence provides a broad profile of thioester-dependent 17-ODYA labeling in T. gondii.
We next assessed how palmitoylation may be involved in distinct aspects of the parasite asexual biology and found that our dataset contained proteins involved in all aspects of the lytic cycle ( Figure 2B ). In addition, we found that 37% of the highly hydroxylamine-sensitive proteins and 19% of sensitive proteins were annotated as hypothetical ( Figure 2C ). Consistent with reports that palmitoylation often occurs proximal to or within transmembrane (TM) domains (Charollais and Van Der Goot, 2009) , we found that TM domain-containing proteins were enriched in the highly hydroxylamine-sensitive proteins in our dataset (37%) compared to a T. gondii membrane proteome (30%) (Che et al., 2011) and the predicted T. gondii proteome (20%) ( Figure 2C ). In addition to TM domains, mammalian palmitoylation is enriched at cysteine residues close to the N terminus of a protein when glycine is the second amino acid, which are frequently myristoylated. Our dataset was not significantly enriched for proteins with glycine in the second position, as 7%-8% of the proteins in our data had a glycine in this position, compared to the T. gondii membrane proteome (7%) (Che et al., 2011) and the predicted proteome (6%) ( Figure 2C ). This lack of enrichment may be an artifact of how we set our selection criteria, as dually acylated proteins may be less sensitive to hydroxylamine treatment.
Recent proteomic studies have defined the P. falciparum palmitome (Jones et al., 2012) . Due to the relatedness of these two organisms, we compared the P. falciparum palmitome and our T. gondii dataset, helping us validate likely palmitoylation events and identify modifications unique to either parasite. We initially converted the entire P. falciparum palmitome dataset (Jones et al., 2012 ) into putative T. gondii orthologs. This analysis (legend continued on next page) identified 391 T. gondii orthologs corresponding to 313 of the 494 P. falciparum proteins. Of these, 63 were shared between our data and the entire P. falciparum palmitome ( Figure 2D , Table  S2 ). We also observed limited overlap between our data and the 17-ODYA-generated P. falciparum palmitome ( Figure 2E , Table  S2 ). The overlap between the datasets was unexpectedly small, which could be due to substantial differences in the way the two parasites use palmitoylation, overall poor homology between palmitoylated proteins in these parasites, or that different life cycle stages are being compared, i.e., intracellular P. falciparum schizonts and extracellular T. gondii tachyzoites.
Validation of Protein Palmitoylation
To confirm that proteins identified in our proteomic analysis were in fact palmitoylated, we carried out direct validation studies in which specific proteins from our dataset were isolated by immunoprecipitation and the presence of the palmitate analog (17-ODYA) confirmed biochemically. MLC1 was previously suggested to be palmitoylated (Fré nal et al., 2010) . We metabolically labeled MLC1-FLAG-expressing parasites (Leung et al., 2014) with 17-ODYA, immunoprecipitated MLC1 with the FLAG epitope, used Click chemistry to attach an azido-rhodamine fluorophore, and analyzed the labeled proteins by SDS-PAGE (Figure 3A) . We observed a strong fluorescent signal associated with MLC1, which was reduced by hydroxylamine treatment. These results are consistent with the MS data and confirm that MLC1 is palmitoylated in tachyzoites. We also identified the MLC1-binding partner MyoA as being putatively palmitoylated in our dataset. We metabolically labeled parasites expressing an N-terminal FLAG-tagged MyoA (Tang et al., 2014) with 17-ODYA. Using the FLAG epitope, we immunoprecipitated MyoA and then labeled with azido-rhodamine. We observed a fluorescent signal associated with MyoA by SDS-PAGE that was lost by treatment with hydroxylamine (Figure 3B ), indicating that MyoA is genuinely palmitoylated. In addition to the rhodamine signal observed for MyoA, we detected fluorescent signals from five other protein species that co-precipitated with MyoA that were similarly hydroxylamine sensitive ( Figure 3B) . Interestingly, the pattern of co-precipitating proteins resembled the profile previously identified as the core components of the glideosome (Fré nal et al., 2010; Gaskins et al., 2004) . Given literature reports and the electrophoretic mobility of the protein species, we tentatively annotated them as GAP45 (a confirmed palmitoylated protein (Child et al., 2013; Fré nal et al., 2010) , MLC1 (shown in this study to be palmitoylated), GAP40, and GAP50 ( Figure 3B ). However, without MS identification of these MyoA-associated proteins we cannot conclusively confirm their identity. GAP40 and GAP50 have not previously been reported to be palmitoylated, but our proteomic data indicated that they likely are, with GAP40 labeling being highly hydroxylamine sensitive and GAP50 hydroxylamine sensitive. We also observed a faint diffuse protein species between 50 and 70 kDa that was specific to the IP and also hydroxylamine sensitive ( Figure 3B ). While the identity of this protein has yet to be confirmed, based on a recent description of alternative glideosome complexes, we believe that this protein is likely either GAP70 or GAP80 (Fré nal et al., 2014; Fré nal et al., 2010) . Consistent with this assignment, GAP80 is present as a highly hydroxylamine-sensitive hit in our dataset. Therefore, our data suggest that the glideosome is a heavily palmitoylated complex in tachyzoites. Inhibition of palmitoylation has been shown to disrupt parasite morphology (Alonso et al., 2012) . Consistent with this, our chemical proteomic approach identified PhIL1, which has been previously implicated in parasite morphology (Barkhuff et al., 2011) , as being palmitoylated. We metabolically labeled parasites expressing a GFP-tagged PhIL1 (Gilk et al., 2006 ) with 17-ODYA. We immunoprecipitated PhIL1 and performed a click reaction with azido-rhodamine, observing a fluorescent signal that was lost upon hydroxylamine treatment, confirming that PhIL1 is also palmitoylated ( Figure 3C ).
AMA1 Is Palmitoylated
Identification of the invasion-associated protein AMA1 Hehl et al., 2000; Lamarque et al., 2014; Mital et al., 2005) as one of the highly hydroxylamine sensitive hits in our dataset was intriguing, as palmitoylation has been implicated in the regulation of host cell invasion (Alonso et al., 2012; Child et al., 2013) . We labeled parasites expressing FLAG-tagged AMA1 (Parussini et al., 2012) with 17-ODYA, immunoprecipitated AMA1 using the FLAG epitope, and labeled with azidorhodamine. We observed a strong fluorescent signal for AMA1 isolated from both extracellular ( Figure 3D ) and intracellular parasites ( Figure S2 ), which was greatly reduced by hydroxylamine treatment, indicating that AMA1 is palmitoylated.
We next sought to identify the site of palmitoylation on AMA1, which contains 18 cysteine residues Hehl et al., 2000) . Structural studies indicate that 16 of these cysteines form disulfide bridges in the protein's extracellular domain and are therefore not likely to be sites of palmitoylation (Crawford et al., 2010) . One of the remaining two cysteines lies within a predicted signal peptide, which is not expected to be part of the mature protein Hehl et al., 2000) . The remaining cysteine is located at position 504 in the C-terminal end of the predicted TM domain, proximal to the cytosolexposed tail region ( Figure 4A ). This particular cysteine is not conserved in P. falciparum and other related Plasmodium species, although several Plasmodium species contain cysteines at other positions within their TM domains ( Figure 4A ). PfAMA1, which lacks this cysteine, was not identified in the P. falciparum palmitome (Jones et al., 2012) . To determine if Cys504 was required for TgAMA1 palmitoylation, we generated parasite strains in which endogenous AMA1 was replaced with either wild-type (WT) FLAG-tagged allele (AMA1 WT ) or a FLAG-tagged allele containing a Cys504Ser mutation (AMA1
C504S
; Figure S3 ). AMA1 C504S parasites were viable and expressed AMA1 C504S at steady-state levels equivalent to those of AMA1 WT ( Figure 4B ). The localization of AMA1
was indistinguishable from AMA1 WT in intracellular ( Figure 4C ) and extracellular parasites ( Figure 4D ): staining was detectable around the entire periphery of the parasite and concentrated at the apical end, as previously described Hehl et al., 2000) . We metabolically labeled both AMA1
WT and the AMA1 C504S strains with 17-ODYA, immunoprecipitated AMA1 using the FLAG epitope, and labeled with azido-rhodamine. AMA1 WT yielded a strong fluorescent signal visualized by SDS-PAGE, whereas the AMA1 C504S showed no detectable rhodamine fluorescence ( Figure 4E ). These data strongly suggest that residue Cys504 is essential for, and likely the site of, palmitoylation on AMA1.
Following secretion from the micronemes to the parasite plasma membrane, AMA1 is cleaved within its TM domain by the rhomboid protease ROM4 (Rugarabamu et al., 2015; Shen et al., 2014) , and its ectodomain is released from the parasite. As Cys504 lies within the AMA1 TM domain, we hypothesized that palmitoylation on this site might regulate AMA1 intramembrane cleavage and shedding. Microneme secretion assays, which measure the combined effect of secretion to the parasite surface and intramembrane proteolysis, revealed a striking increase in the amount of AMA1 C504S ectodomain released in the culture supernatant compared to AMA1 WT (Figures 5A and S4C) . Surprisingly, a similar increase was observed for the shedding of the microneme protein 2 (MIC2) in the AMA1 C504S parasites ( Figure 5D ), suggesting that AMA1 palmitoylation influences the rate of microneme secretion. Secretion of a dense granule marker (GRA7) and rhoptry marker (ROP1) was unaffected ( Figures 5A, S4C , and S4D), indicating that increased secretion in the mutant is restricted to micronemes and is not observed for other apical complex organelles. In standard plaque assays, AMA1 C504S parasites consistently formed 40% fewer plaques than AMA1 WT . However, the plaques that formed were of roughly equal size ( Figure 5B ), and the mutant parasites showed no detectable defect in invasion ( Figure 5C ). Since the mutant parasites formed fewer plaques but invaded normally, we tested whether the AMA1 C504S plaquing defect resulted from an inability to complete the intracellular phase of the lytic cycle. In initial replication assays with freshly egressed parasites, we observed no difference in parasite intracellular growth (data not shown). When the parasites were incubated extracellularly for 4-5 hr before addition to host cells, there was still no difference in the invasiveness of AMA1 C504S and AMA1 WT parasites ( Figure S4E ). However, a smaller percentage of the aged AMA1 C504S parasites that invaded were able to complete their intracellular replicative cycle compared to aged AMA1 WT parasites ( Figure 5D ), likely explaining the reduced number of plaques observed in the mutants despite their similar levels of invasion. Finally, recent studies have shown that in the absence of AMA1, parasites upregulate AMA2 as a Error bars indicate SD; NS, not significant.
C504S is defective at transitioning from one parasite/vacuole to two parasites/vacuole after being extracellular for 4 hr. Histogram presents quantification of three independent replication assays. Number of parasites/parasitophorous vacuole is indicated. Significance was calculated using Sidak's multiple comparisons test (**p = 0.0092, *p = 0.019). Error bars denote SD. See also Figure S4 .
compensatory response (Lamarque et al., 2014) . To investigate if a similar compensation had occurred, we compared the expression levels of AMA2 and AMA4 by qPCR in the wild-type and C504S mutant (Figures S4A and S4B ). AMA4 expression levels were unchanged; however, there was a slight, but significant, downregulation of AMA2 in the mutant. The underlying biological significance and relationship to our phenotype remain to be determined.
DISCUSSION
S-palmitoylation is the post-translational addition of a saturated 16-carbon fatty acid onto proteins via cysteine thiols (Tom and Martin, 2013) . Modern approaches enable proteome-wide identification of proteins modified by palmitate (Martin and Cravatt, 2009 ). These ''palmitomes'' have confirmed the presence of this PTM through diverse aspects of biology and across disparate branches of the tree of life. For example, a recent study defined the palmitome of the apicomplexan parasite, P. falciparum, concluding that palmitoylation plays a central role in regulating blood-stage development (Jones et al., 2012) .
Here, we applied a comprehensive DIA-MS chemoproteomic approach to study palmitoylation of a related apicomplexan parasite, T. gondii. Focusing on the asexual tachyzoite stage, we discovered that palmitate is incorporated onto proteins involved in all aspects of the tachyzoite lytic cycle, identifying the majority of proteins previously predicted to be palmitoylated in T. gondii (Table 1) . Additionally, using a biochemical method developed in our previous study (Child et al., 2013) , we validated our dataset and showed that multiple proteins not previously known to be palmitoylated are modified by this PTM. Despite growing knowledge of specific sites of palmitoylation, recognition motifs that direct modification remain poorly defined (Linder and Deschenes, 2007; Salaun et al., 2010) . It is not clear if the rules or motifs are evolutionarily conserved or if they are specific to a given organism of interest. CSS-Palm (http://csspalm. biocuckoo.org/) is open-source software that provides a bioinformatic prediction of the likelihood that a given cysteine will be palmitoylated (Ren et al., 2008) . CSS-Palm 4.0 predicts with high confidence that approximately 56% percent (4,755/8,460) of the coding genes in T. gondii produce potentially palmitoylated proteins, compared with the 282 proteins identified in our dataset (3.3% of the coding sequences in the genome). Consistent with our data, CSS-Palm 4.0 predicts with high confidence that AMA1 is palmitoylated. However, the software identifies a cysteine within the predicted signal peptide of the molecule as the likely site of modification, not Cys504, which we identified as the likely site of palmitoylation. Our findings indicate that caution should be exercised when using bioinformatic approaches to identify palmitoylated proteins.
In this study, we present the use of DIA-MS, an approach that enables cross-experiment data extraction and quantitation for improved label-free statistical analysis. While this approach provides robust statistical power for label-free analysis, the data are likely inherently biased toward more abundant proteins or proteins with higher modification stoichiometry. In addition, thresholds applied to the hydroxylamine treatment dataset will group proteins that are palmitoylated along with proteins modified by multiple lipid acylations (e.g., palmitoylated and myristoylated).
Given that T. gondii is often described as a model organism for P. falciparum (Kim and Weiss, 2004) , the limited overlap between the published palmitome for this related parasite and our dataset is surprising. This lack of overlap may be due to low homology between the species and subsequent difficulty in identifying orthologs in silico. However, the biology of these two organisms differs in many respects, and the lack of overlap may indicate that most palmitoylation is parasite specific. A good example of this is demonstrated here; TgAMA1 is palmitoylated, while PfAMA1 is not (Jones et al., 2012) . Conversely, proteins that do overlap between datasets could represent evolutionarily conserved palmitoylation events.
Highlighting the critical role palmitoylation likely plays in the formation and/or function of the glideosome complex, we identified most components of the MyoA glideosome (MyoA, MLC1, GAP45, GAP40, and GAP50) within the MS dataset as palmitoylated protein species (Table S1 ). Moreover, a recent study investigating functional plasticity of glideosome components described an alternative, basally localized glideosome complex referred to as the MyoC glideosome (Fré nal et al., 2014) . Consistent with the underlying functional significance of palmitoylation for the glideosome, our proteomic study identified GAP80 and IAP1, two components of the MyoC glideosome (Fré nal et al., 2014) as highly hydroxylamine-sensitive hits. Notably, MyoC was absent from our data.
We have shown that AMA1 in T. gondii has a previously unidentified palmitoylation site. Although AMA1 has been implicated in attachment and/or invasion (Bargieri et al., 2013 (Bargieri et al., , 2014 Hehl et al., 2000; Lamarque et al., 2014; Mital et al., 2005; Tyler et al., 2011) , parasites expressing the AMA1 palmitoylation site mutant invade normally. One phenotype associated with mutation of the AMA1 palmitolyation site is a marked increase in the secretion of AMA1 and other microneme proteins, suggesting a previously unrecognized role for AMA1 in regulating microneme secretion. We also observed that mutant parasites that remain extracellular for 4 hr prior to invasion are less likely to complete their lytic cycle. The biological relevance of this observation is unclear. It may reflect involvement of TgAMA1 in intracellular replication, which would be consistent with the previous suggestion that intramembrane cleavage of TgAMA1 triggers parasite replication (Santos et al., 2011) . However, other work has shown that parasites expressing non-cleavable mutants of TgAMA1 (Parussini et al., 2012) or lacking AMA1 altogether (Bargieri et al., 2013) replicate indistinguishably from wild-type, as do parasites lacking the rhomboid proteases necessary for TgAMA1 intramembrane cleavage (Rugarabamu et al., 2015; Shen et al., 2014) , casting doubt on the connection between TgAMA1 cleavage and replication initiation. Palmitoylation of AMA1 could instead be involved in some previously unidentified function of the protein, such as fission of the parasitophorous vacuole membrane from the host cell plasma membrane during the final stages of invasion, although this would not explain why the phenotype only manifests after the parasites have been extracellular for 4 hr. It could be that enhanced secretion of microneme proteins in AMA1 C504S parasites while extracellular exhausts them of a protein normally secreted from the micronemes intracellularly, which is needed to complete the lytic cycle. Further studies will be required to test the hypothesis that microneme secretion occurs intracellularly and plays a role in the parasite's lytic cycle. Finally, it is formally possible that phenotypes observed are not a direct consequence of the mutation introduced into AMA1, but rather a compensatory change induced by the mutation (Fré nal and Soldati-Favre, 2015) such as downregulated expression of AMA2 ( Figure S4A ). Recent studies dissecting the function of AMA1 cleavage from the surface of the parasite by the rhomboid proteases ROM4 and ROM5 have determined that the bulk of AMA1 is cleaved by ROM4, with a small proportion cleaved by ROM5 (Rugarabamu et al., 2015; Shen et al., 2014) . Our data indicate that ROM4 is palmitoylated, and so palmitoylation could be a mechanism to organize enzyme and substrate. Furthermore, Rugarabamu and colleagues suggest that ''The restricted access of ROM5 to a large pool of AMA1 is plausibly due to distinct lipid microenvironment or more likely as a result of compartmentalization,'' (Rugarabamu et al., 2015) . It is intriguing to speculate that when AMA1 is not palmitoylated a greater proportion of the pool can be accessed by ROM5 and that the shift in the pools of the AMA1 accessed by ROM4 and ROM5 functionally contributes to the phenotypes observed herein.
In conclusion, we have generated a dataset that implicates palmitoylation in distinct aspects of Toxoplasma biology and have validated the palmitoylation of several proteins. In the case of extensively studied TgAMA1, we have shown that mutation of the likely palmitoylation site has no effect on invasion but causes a marked increase in microneme secretion, suggesting a role for AMA1 in this process. We have shown that this dataset can unlock unexpected biology for even the most well-studied proteins and will be a powerful resource for the future.
EXPERIMENTAL PROCEDURES
Labeling with 17-ODYA and Palmitic Acid Parasites were labeled overnight (16 hr) in culture medium with 25 mM palmitic acid or 25 mM 17-ODYA. Parasites were isolated by syringe lysis from HFFs, spun at 1200 3 g for 5 min to remove host cell debris. Intracellular parasites were labeled as described, with infected host cells scraped, spun down, and washed in PBS to collect intracellular parasites.
Validation of Palmitoylation
Labeled parasites were lysed by sonication in 13 PBS with 10 mM PMSF and 20 mM HDSF. Membranes were pelleted by centrifugation at 100,000 3 g for 1 hr at 4 C. Protein concentration was assessed by BCA. GFP IP setup was as follows: 60 ml of GFP-TRAP A beads from Chromotek were incubated with 200 mg of membrane lysate and IP buffer (150 mM NaCl, 20 mM HEPES [pH 7.4], 0.1% SDS, 0.5% NP40) for a total volume of 200 ml. IPs were incubated overnight at 4 C, then washed 33 with cold IP buffer, 23 with cold wash buffer (150 mM NaCl, 20 mM HEPES [pH 7.4]), and once with cold 13 PBS. Beads were resuspended in a 50 ml click reaction (1 mM CuSO 4 , 1 mM TCEP, 100 mM Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine [ligand] , and 20 mM Azido-Rhodamine in 13 PBS). Reactions were incubated for 1 hr at 23 C, then split in half. NH 2 OH (5% of total) was added to half of the reaction and incubated for 30 min at 23 C. Protein was eluted from beads by boiling in sample buffer and separated by SDS-PAGE. FLAG IPs were performed as for GFP, using 60 ml Sigma anti-FLAG M2 affinity gel. Gels were scanned on an Amersham Bioscience Typhoon 9410 variable mode imager using the 580 bp Filter with the green 532 laser. Gels were transferred to nitrocellulose and westerns performed to confirm IP of protein of interest. Western blots for AMA1 were performed using UVT-59 , for TgMLC1 using anti-TgMLC1, for FLAG using anti-FLAG M2 (Sigma), and for GFP using the GF28R (Thermo Scientific) antibody.
For inputs, 50 mg of membrane lysate were added to a 50 ml click reaction described above. Reactions were incubated for 1 hr at 23 C and boiled in sample buffer. 5 mg were loaded for each input.
Invasion and Plaque Assays
Laser scanning cytometer-based invasion assays were done as previously described (Mital et al., 2005) , with the following modifications: (a) the parasites were allowed to settle onto the HFF monolayers for 20 min at 23 C before incubation at 37 C for 1 hr; and anti-SAG1 primary, RPE-conjugated secondary, and Alexa 647-conjugated secondary antibodies were used at dilutions of 1:250, 1:400, and 1:200, respectively. A total of three biological replicates (each done in duplicate) were performed; Student's t test was applied to the means of the biological replicates.
Plaque assays were set up immediately following the initiation of invasion assays, using the same parasite suspensions. Fifty parasites were added to each well of a 12-well plate containing confluent host cell HFF monolayers. The plate was incubated for 7 days in the 37 C incubator with 5% CO 2 and humidity, then stained with 2% crystal violet and 20% methanol in PBS for 5 min at 23
C. The stained wells were washed with water, and the number of plaques per well were counted.
Replication Assay WT and C504S parasites were harvested and allowed to sit at 23 C for 4 hr in DMEM with 1% FBS. Parasites were counted, and 5 3 10 5 parasites were added to 25 mm coverslips with confluent human foreskin fibroblasts. After 14 hr, coverslips were fixed on ice with 100% cold methanol for 5 min. Indirect IFAs were performed using anti-GRA8 and anti-GAP45 antibodies as previously described (Carey et al., 2000) . A total of three biological replicates were performed with triplicates in each, and 250 vacuoles were counted per coverslip. Two-way ANOVA with Sidak's multiple comparisons test was performed. Additional details can be found in the Supplemental Information. 
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